These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 32108622

  • 1. A grading dilemma; Gleason scoring system: Are we sufficiently compatible? A multi center study.
    Dere Y, Çelik ÖI, Çelik SY, Ekmekçi S, Evcim G, Pehlivan F, Ağalar A, Deliktaş H, Çulhacı N.
    Indian J Pathol Microbiol; 2020 Feb; 63(Supplement):S25-S29. PubMed ID: 32108622
    [Abstract] [Full Text] [Related]

  • 2. A comparison of interobserver reproducibility of Gleason grading of prostatic carcinoma in Japan and the United States.
    Oyama T, Allsbrook WC, Kurokawa K, Matsuda H, Segawa A, Sano T, Suzuki K, Epstein JI.
    Arch Pathol Lab Med; 2005 Aug; 129(8):1004-10. PubMed ID: 16048389
    [Abstract] [Full Text] [Related]

  • 3. Interobserver variability in Gleason histological grading of prostate cancer.
    Ozkan TA, Eruyar AT, Cebeci OO, Memik O, Ozcan L, Kuskonmaz I.
    Scand J Urol; 2016 Dec; 50(6):420-424. PubMed ID: 27416104
    [Abstract] [Full Text] [Related]

  • 4. Interobserver reproducibility of Gleason grading of prostatic adenocarcinoma among general pathologists.
    Singh RV, Agashe SR, Gosavi AV, Sulhyan KR.
    Indian J Cancer; 2011 Dec; 48(4):488-95. PubMed ID: 22293266
    [Abstract] [Full Text] [Related]

  • 5. Automated deep-learning system for Gleason grading of prostate cancer using biopsies: a diagnostic study.
    Bulten W, Pinckaers H, van Boven H, Vink R, de Bel T, van Ginneken B, van der Laak J, Hulsbergen-van de Kaa C, Litjens G.
    Lancet Oncol; 2020 Feb; 21(2):233-241. PubMed ID: 31926805
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Expected impact of MRI-targeted biopsy interreader variability among uropathologists on ProScreen prostate cancer screening trial: a pre-trial validation study.
    Hietikko R, Mirtti T, Kilpeläinen TP, Tolonen T, Räisänen-Sokolowski A, Nordling S, Hannus J, Laurila M, Taari K, Tammela TLJ, Autio R, Natunen K, Auvinen A, Rannikko A.
    World J Urol; 2024 Apr 06; 42(1):217. PubMed ID: 38581590
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Evaluation of the interobserver reproducibility of Gleason grading of prostatic adenocarcinoma using tissue microarrays.
    De la Taille A, Viellefond A, Berger N, Boucher E, De Fromont M, Fondimare A, Molinié V, Piron D, Sibony M, Staroz F, Triller M, Peltier E, Thiounn N, Rubin MA.
    Hum Pathol; 2003 May 06; 34(5):444-9. PubMed ID: 12792917
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Accuracy of gleason grading by practicing pathologists and the impact of education on improving agreement.
    Mikami Y, Manabe T, Epstein JI, Shiraishi T, Furusato M, Tsuzuki T, Matsuno Y, Sasano H.
    Hum Pathol; 2003 Jul 06; 34(7):658-65. PubMed ID: 12874761
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Impact of prostate biopsy secondary pathology review on radiotherapy management.
    Siedow M, Eisner M, Yaney A, Washington I, Zynger D, Martin D, Mo X, Diconstanzo D, Diaz DA.
    Prostate; 2022 Feb 06; 82(2):210-215. PubMed ID: 34698410
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.